Ares Management is backing the continuation fund, an increasingly popular tool for private-credit managers to return cash to their investors.

When Eli Lilly snapped up Scorpion Therapeutics' PI3Kα program earlier this year, the deal allowed Scorpion to spin out a new ...

It was meant to be a routine rocket launch to resupply the International Space Station, the fifth mission sent with that objective, and all witnesses expected yet another successful take-off of the ...

Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and ...

The spinout, dubbed Antares Therapeutics, will be fueled by a $177 million series A round co-led by Omega Funds, Atlas ...

The waxing gibbous moon will shine close to the red star Antares in the constellation Scorpius on the night of June 9.

Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...

Late last month, Firefly announced that Northrop Grumman has invested $50 million into accelerating the development of the ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

Antares Therapeutics has launched with $177 million in series A financing and a staff already at full speed, according to CEO Adam Friedman. The company is a spin-off of Scorpion Therapeutics, which ...